• Scientific Excellence

  • Ebola Research: Bedside to Bench

  • Biomedical Technology

  • HIV/AIDS Vaccine Discovery

  • Active Clinical Trials

Vaccine Philanthropy

Philanthropic donations provide seed funding for elite junior scientists working toward understanding, preventing and curing HIV/AIDS. This funding mechanism is critical in expanding the scope of HIV and AIDS research at the Emory Vaccine Center. These funds lead to discoveries and progress in the fight to combat HIV/AIDS on a global scale.

Learn More »

Help Us Save Lives

YOUR HELP LEADS... To pioneering studies promising vaccines. To the purchase of cutting-edge equipment. To critical clinical trials and testing. On average, each private funding dollar the Emory Vaccine Center receives is leveraged to acquire 17 additional research dollars in the form of prestigious federal grants.

Learn More »

Ebola Update

Ebola survivors are protected from ebola virus years after illness. Scientists have charted how the antibodies of a person infected with Ebola virus evolve over time and the findings suggest that survivors remain protected from the disease for at least three years after recovery.

Learn More »

Reserve Your Spot

Featuring: Rino Rappuoli, Chief Scientist & Head of External Research and Development at GlaxoSmithKline Vaccines Kathleen Neuzil, Director, Center for Vaccine Development and Global Health, University of Maryland Martin Blazer, Director, Center for Advanced Biotechnology and Medicine, Rutgers University David Bloom, Professor, Department of Global Health and Population, Harvard School of Public Health Keith Klugman, Director, Pneumonia Program, Gates Foundation

Sign-Up »